Neal B - Search Results

1

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.

Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Rafter N, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A; Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. Patel A, et al. Among authors: neal b. Eur J Prev Cardiol. 2015 Jul;22(7):920-30. doi: 10.1177/2047487314530382. Epub 2014 Mar 27. Eur J Prev Cardiol. 2015. PMID: 24676715 Clinical Trial.

2

Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease.

MacMahon S, Neal B, Rodgers A. MacMahon S, et al. Among authors: neal b. Schweiz Med Wochenschr. 1995 Dec 26;125(51-52):2479-86. Schweiz Med Wochenschr. 1995. PMID: 8571098 Review.

3

Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) pilot phase.

Neal B, Anderson C, Chalmers J, MacMahon S, Rodgers A. Neal B, et al. Clin Exp Pharmacol Physiol. 1996 May;23(5):444-6. doi: 10.1111/j.1440-1681.1996.tb02758.x. Clin Exp Pharmacol Physiol. 1996. PMID: 8713688 Clinical Trial.

4

Forty years of randomised trials in the New Zealand Medical Journal.

Neal B, Rodgers A, Mackie MJ, MacMahon S. Neal B, et al. N Z Med J. 1996 Oct 11;109(1031):372-3. N Z Med J. 1996. PMID: 8890875 Review.

5

Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study.

Whitlock G, MacMahon S, Anderson C, Neal B, Rodgers A, Chalmers J. Whitlock G, et al. Among authors: neal b. Clin Exp Hypertens. 1997 Jul-Aug;19(5-6):843-55. doi: 10.3109/10641969709083190. Clin Exp Hypertens. 1997. PMID: 9247759 Clinical Trial.

6

Less salt does not necessarily mean less taste.

Rodgers A, Neal B. Rodgers A, et al. Among authors: neal b. Lancet. 1999 Apr 17;353(9161):1332. doi: 10.1016/S0140-6736(99)01198-8. Lancet. 1999. PMID: 10218541 No abstract available.

7

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery.

Neal BC, Rodgers A, Clark T, Gray H, Reid IR, Dunn L, MacMahon SW. Neal BC, et al. Acta Orthop Scand. 2000 Apr;71(2):122-8. doi: 10.1080/000164700317413076. Acta Orthop Scand. 2000. PMID: 10852316 Review.

8

No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients.

Neal BC, Rodgers A, Gray H, Clark T, Beaumont DD, House T, Douglas JE, Reid IR, MacMahon SW. Neal BC, et al. Acta Orthop Scand. 2000 Apr;71(2):129-34. doi: 10.1080/000164700317413085. Acta Orthop Scand. 2000. PMID: 10852317 Clinical Trial.

9

Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.

Neal B, Rodgers A, Dunn L, Fransen M. Neal B, et al. Cochrane Database Syst Rev. 2000;(3):CD001160. doi: 10.1002/14651858.CD001160. Cochrane Database Syst Rev. 2000. PMID: 10908488 Updated. Review.

10

Blood pressure lowering in diabetes: a brief review of the current evidence and description of a new trial.

Patel A, Chalmers J, Neal B, Chapman N, Girgis S, MacMahon S. Patel A, et al. Among authors: neal b. Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1108-11. doi: 10.1046/j.1440-1681.2001.03581.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11903327 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

713 results

Search Page